Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Nitrous oxide cylinders size E
1501020R0BBADA0
|
Nitrous oxide | Nitrous oxide | Anaesthesia | 4 |
|
Nitrous oxide 50% / Oxygen 50%
1501020R0AAAHAH
|
Nitrous oxide/oxygen | Nitrous oxide | Anaesthesia | 3 |
|
Entonox cylinders size ED
1501020R0BCAIA0
|
Entonox | Nitrous oxide | Anaesthesia | 2 |
|
Entonox cylinders size D
1501020R0BCAAAH
|
Entonox | Nitrous oxide | Anaesthesia | No data available |
|
Entonox cylinders size EA
1501020R0BCAHA0
|
Entonox | Nitrous oxide | Anaesthesia | No data available |
|
Entonox cylinders size EW
1501020R0BCAKAH
|
Entonox | Nitrous oxide | Anaesthesia | No data available |
|
Entonox cylinders size EX
1501020R0BCAJA0
|
Entonox | Nitrous oxide | Anaesthesia | No data available |
|
Entonox cylinders size F
1501020R0BCABA0
|
Entonox | Nitrous oxide | Anaesthesia | No data available |
|
Entonox cylinders size G
1501020R0BCACA0
|
Entonox | Nitrous oxide | Anaesthesia | No data available |
|
Entonox cylinders size HX
1501020R0BCAEA0
|
Entonox | Nitrous oxide | Anaesthesia | No data available |
|
Entonox cylinders size ZD
1501020R0BCAFA0
|
Entonox | Nitrous oxide | Anaesthesia | No data available |
|
Entonox cylinders size ZX
1501020R0BCAGA0
|
Entonox | Nitrous oxide | Anaesthesia | No data available |
|
Nitrous oxide cylinders size D
1501020R0BBAAA0
|
Nitrous oxide | Nitrous oxide | Anaesthesia | No data available |
|
Nitrous oxide cylinders size F
1501020R0BBACA0
|
Nitrous oxide | Nitrous oxide | Anaesthesia | No data available |
|
Nitrous oxide cylinders size G
1501020R0BBABA0
|
Nitrous oxide | Nitrous oxide | Anaesthesia | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.